Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.52 |
| ▸ | TYMP | P19971 | 4/20 | 0.48 |
| ▸ | PI4KA | P42356 | 4/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 4/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 4/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.47 |
| ▸ | ADA | P00813 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12067762 | 0.93 | BCHE (0.49) | BCHEADORA1TYMPPI4KAPI4K2B | |
| SCHEMBL22458598 | 0.88 | TYMP (0.63) | BCHEADORA1TYMP | |
| SCHEMBL15488823 | 0.88 | TYMP (0.47) | BCHEADORA1TYMPPI4KAPI4K2B | |
| SCHEMBL10697042 | 0.83 | BCHE (0.53) | BCHEADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL31484190 | 0.82 | ADORA1 (0.59) | BCHEADORA1TYMPNT5EAHCY | |
| SCHEMBL6276457 | 0.82 | ADORA1 (0.54) | BCHEADORA1TYMPNT5EAHCY | |
| SCHEMBL10427715 | 0.82 | BCHE (0.55) | BCHEADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL22458596 | 0.82 | TYMP (0.56) | BCHEADORA1TYMP | |
| SCHEMBL23641782 | 0.82 | BCHE (0.42) | BCHEADORA1TYMPPI4KAPI4K2B | |
| SCHEMBL7065756 | 0.82 | TYMP (0.71) | ADORA1TYMPTP53ADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | AJINOMOTO CO., INC (JP) | 2003-10-30 | — | — | US | disclosed |
| US-6579976-B2 | Producing compounds having sugar-moiety hydroxyl groups or halogen atoms reduced in nucleic acids by allowing O-thiocarbonyl derivatives or halogenated derivatives in the sugar-moiety react with hypophosphorous acids or salts | AJINOMOTO CO., INC. (JP) | 2003-06-17 | — | — | US | disclosed |
| US-20020045744-A1 | PROCESS FOR PRODUCING NUCLEIC ACID DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2002-04-18 | — | — | US | disclosed |
| JP-2000198796-A | PRODUCTION OF NUCLEIC ACID DERIVATIVE | AJINOMOTO CO INC | 2000-07-18 | — | — | JP | disclosed |
| EP-0999218-A1 | Process for producing nucleoside derivatives | Ajinomoto Co., Inc. (JP) | 2000-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | RNGTT, DOHH, NT5C3B | BCHE 2179/4885ADORA1 2863/4885TYMP 38/4885 |
| US-20020045744-A1 | PROCESS FOR PRODUCING NUCLEIC ACID DERIVATIVES | RNGTT, OSGEP, PNP | BCHE 2688/4885ADORA1 2231/4885TYMP 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.